3-53888465-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021237.5(SELENOK):c.38G>A(p.Arg13Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,610,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021237.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SELENOK | ENST00000495461.6 | c.38G>A | p.Arg13Gln | missense_variant | Exon 2 of 5 | 1 | NM_021237.5 | ENSP00000418813.1 | ||
SELENOK | ENST00000485414.1 | n.270G>A | non_coding_transcript_exon_variant | Exon 3 of 3 | 5 | |||||
SELENOK | ENST00000487571.1 | n.105G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
SELENOK | ENST00000488746.1 | n.38G>A | non_coding_transcript_exon_variant | Exon 2 of 5 | 3 | ENSP00000417272.1 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000299 AC: 74AN: 247720Hom.: 0 AF XY: 0.000342 AC XY: 46AN XY: 134550
GnomAD4 exome AF: 0.000205 AC: 299AN: 1458336Hom.: 0 Cov.: 29 AF XY: 0.000214 AC XY: 155AN XY: 725658
GnomAD4 genome AF: 0.000381 AC: 58AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.38G>A (p.R13Q) alteration is located in exon 2 (coding exon 2) of the SELK gene. This alteration results from a G to A substitution at nucleotide position 38, causing the arginine (R) at amino acid position 13 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at